Destroying the Antiviral medicine mythologies…
This will be a growing series of postings prepared by a healthcare consumer, also a great-grandfather webmaster of 75/years and counting. The topic of discussion will center around; ‘Are there antiviral medicines or not’?
Viruses are among the most common microbes affecting humans. These microscopic organisms spread easily, usually via person-to-person contact or through exposure to body fluids, such as blood, mucous or saliva. Once inside the body, viruses reproduce quickly, sometimes overwhelming the body’s natural defenses. When this happens, viruses can cause different diseases, some mild and others potentially fatal. Unfortunately only a handful of effective antiviral medications exist. Most of the time, treatment for a viral infection involves dealing with the symptoms until the end of the infection. (emphasis added)
Common Cold – Influenza – Chicken Pox – Rotavirus – Herpes –
Hepatitis – Yellow Fever – Encephalitis – HIV/AIDS – Human Papillomavirus
for the purposes of this blog we add
Dengue Fever – Cancer
We should beg the question; “Are there antiviral medicines, or not?
In the publics interest, have we been lied to for more than a life-time?
The article used in this blog posting is solely for the purpose of shattering the Antiviral smoke screen fog.
As a health-care consumer, having 75+/years of exposure to the market, when it suits the broadcasting of patented, or soon to be patented (new) medicines or vaccines, there antiviral capacities become evident, maybe in less than full disclosures that would truly serve the publics interest and right to know what they are ingesting.
Hepatitis C Virus Therapy Update 2013 – Lisa C. Casey, William M. Lee |
Curr Opin Gastroenterol. 2013;29(3):243-249.
Recent findings: Boceprevir-based and telaprevir-based triple therapy with pegylated interferon and ribavirin marked the beginning of a new era in HCV therapy for genotype 1 patients. New direct-acting antivirals (DAAs) are being developed and new antiviral drug targets are being explored. New combination treatment regimens are expected to emerge soon and there is hope for interferon-free regimens. (emphasis, and or reformatting of original article has been added to enhance clarity of this posting)
New direct-acting antivirals (DAAs)
New combination treatment regimens
New directing antivirals (DAA); should we view them as being different from the antiviral properties, such as found in the leaves of papaya trees, neem trees, melaleuca trees, camote leaves, or weeds like tawa tawa, which have been known for thousands of years. I’m just intrigued?
New combination treatment regimens; will this triple based treatment format resemble that which makes paying subscribers of citizens for brand name patented drugs, for what amounts to ½ cures such as the prescribed treatments for type 1 diabetics, or HIV/AIDS patient treatment regimens. Regimens then take on the ominous shadow of becoming a life-time membership club based on the ability to pay or to be conveniently government subsidized by tax payers.
Summary: …Experience has shown improved response rates and treatment durations for many patients with genotype 1 HCV infection. However, persistent limitations to HCV treatment still exist for patients with prior treatment failure and comorbid conditions and patients on newer therapies suffer additional therapy-limiting side effects and drug–drug interactions. Genetic testing may provide some guidance but additional options for therapy are still needed for HCV. Many new drugs are currently under investigation and there is hope that effective and well tolerated interferon-free regimens may become a part of future therapy.
patients on newer therapies suffer additional therapy-limiting side effects and drug–drug interactionst
Many new drugs are currently under investigation
Comparing the new DAA to ancient papaya leaf extract (PLX), since 2008 when discovered by Dr. Hettige has not been reported to have any side effects on adults, children, or infants. The papaya leaf extract cure (PLXC), in some regions of India, has become so well known for its healing properties in regards to dengue fever, nursery suppliers of plants and trees can not keep up with the market demand. This public response should have been ongoing since 2008. Think how many graves would not have been dug in the now past 5/year period.
The Era of Triple Therapy
The creation of the new standard ‘triple therapy’ with the DAA medications has led to significant improvements in the response rates for patients with genotype 1 HCV, with SVR rates as high as 63–75% and reduction in duration of therapy by half for many patients based on response-guided therapy (RGT). The first Food and Drug Administration (FDA)-approved protease inhibitors, telaprevir and boceprevir,are designed to mimic the natural NS3/NS4A protease substrate in genotype 1 HCV, therefore inhibiting the onset of the replication process. The successes, failures, and new challenges of triple therapy have become well known. Although the advent of triple therapy has dramatically improved outcomes for many, therapeutic options for HCV are still far from optimal. Many new side effects have been encountered with creative management strategies developed, drug interactions have taken on new importance and issues with resistance and intolerance persist. With the explosion of research and development of newer DAA and additional therapeutic targets, we are at the very beginning of a new era in HCV therapy. A review of the lessons learned from the beginning will be important as we move forward.
the new standard ‘triple therapy’ with the DAA medications
The first Food and Drug Administration (FDA)-approved protease inhibitors, telaprevir and boceprevir
are designed to mimic the natural NS3/NS4A protease substrate in genotype 1 HCV
Many new side effects have been encountered with creative management strategies developed
drug interactions have taken on new importance and issues with resistance and intolerance persist
If you carefully read each of the above bulleted items, how can you not conclude, citizens of the world are being used as pawns in the dangerous scientific games of research institutions striving for example to; “…mimic the natural NS3/NS4A protease substrate in genotype 1 HCV”.
For the purpose of attempting to derive a great benefit from resolving the antiviral flip flopping in the contemporary medicine practices of today, this topic of discussion will be posted as a series. Comments and questions will be apart of each posting so we will be able to learn from each other.
Looking for feedback- please…
About PLXC-CTC Dengue Remedies
Let the sunshine in,/Nicasio Martineznm
Alert– for accredited scientific studies and research by institutions and individuals, clicking on the following link is a must— papayaleaves.wordpress.com
Truth is a gem you have to search out, deeply and far beyond readily available institutions that assail your ears, eyes, thoughts, feelings, and emotions.
Disclaimer: As a Great-grandfather family webmaster, what I share should never be accepted as being medical advice, merely a sharing of easily re–searchable links for the purpose of educational sharing in the public interest.
You should research for yourself and make your best intelligent decisions— even before or after consulting with medical professionals who have earned your trust. /Nicasio Martinez